An observational study of Pembrolizumab in recurrent high-grade glioma patients with mismatch repair deficiency
Latest Information Update: 12 Feb 2020
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Glioma
- Focus Therapeutic Use
Most Recent Events
- 08 Jun 2019 New trial record
- 04 Jun 2019 Results demonstrating efficacy of Pembrolizumab in mismatch repair deficiency glioma presented at the 55th Annual Meeting of the American Society of Clinical Oncology.